1 active not recruiting, 1 completed. 2 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 2 | Active not recruiting 1, Completed 1 |
Follow Endomyocardial Fibrosis: new trials by email Literature Review of Endomyocardial Fibrosis trials Research Report on Endomyocardial Fibrosis
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| The COlchicine HypERtENsion Trial Colchicine, Placebo - Hypertension | Phase 2 | Active not recruiting | Herlev and Gentofte Hospital | 150 | 2021-08-10 | 2025-12-22 |
| Spironolactone in Adult Congenital Heart Disease Spironolactone 25mg, Placebo - Congenital Heart Disease, Heart Failure | Phase 2 | Completed | Oregon Health and Science University | 40 | 2010-02-01 | 2019-08-21 |
Atherosclerosis (1) · Cardiovascular Diseases (1) · Coronary Artery Disease (1) · Heart Defects, Congenital (1) · Heart Diseases (1) · Heart Failure (1) · Hypertension (1) · Hypertrophy, Left Ventricular (1) · Inflammation (1)
Cardiomyopathies (2) · Arterial Occlusive Diseases (1) · Arteriosclerosis (1) · Cardiomegaly (1) · Cardiovascular Abnormalities (1) · Cardiovascular Diseases (1) · Congenital Abnormalities (1) · Congenital, Hereditary, and Neonatal Diseases and Abnormalities (1) · Coronary Disease (1) · Heart Diseases (1) · Hypertrophy (1) · Myocardial Ischemia (1) · Pathologic Processes (1) · Pathological Conditions, Anatomical (1) · Pathological Conditions, Signs and Symptoms (1)
Colchicine (1) · Spironolactone (1)
Herlev and Gentofte Hospital (1) · Oregon Health and Science University (1)
Denmark (1) · United States (1)
Craig Broberg, MD (1) · Niklas Dyrby Johansen, MD (1)
K23HL093024 (1)